BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10718857)

  • 1. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.
    Gao J; Zhou W; Chen B; Lin W; Wu S; Wu F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2703-2710. PubMed ID: 28979112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of inflammation and the use of reversibility testing in smokers with airway complaints.
    Chavannes NH; Vernooy JH; Schermer TR; Jacobs JA; Dentener MA; van Weel C; van Schayck OC; Wouters EF
    BMC Pulm Med; 2006 Jun; 6():11. PubMed ID: 16740168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of eosinophil cationic protein and lactate dehydrogenase in asthma: a comparative study of serum versus sputum.
    Al Obaidi AH; Al Samarai AG; Al-Janabi J; Yahia A
    World Allergy Organ J; 2009 Jul; 2(7):144-9. PubMed ID: 23283064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil-mucus interplay in severe asthma: Implications for treatment with biologicals.
    Venegas Garrido C; Mukherjee M; Svenningsen S; Nair P
    Allergol Int; 2024 Jul; 73(3):351-361. PubMed ID: 38485545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD.
    Correnti S; Preianò M; Gamboni F; Stephenson D; Pelaia C; Pelaia G; Savino R; D'Alessandro A; Terracciano R
    J Transl Med; 2024 Mar; 22(1):301. PubMed ID: 38521955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of anti-elastin antibody in patients with asthma.
    Tokita S; Sugiyama K; Wakayama T; Arifuku H; Otsuji N; Sugitate K; Owada T; Koyama K; Hirata H; Arima M; Ueda Y; Fukushima Y
    Asian Pac J Allergy Immunol; 2021 Jul; ():. PubMed ID: 34246206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparameter Single Cell Profiling of Airway Inflammatory Cells.
    Yao Y; Welp T; Liu Q; Niu N; Wang X; Britto CJ; Krishnaswamy S; Chupp GL; Montgomery RR
    Cytometry B Clin Cytom; 2017 Jan; 92(1):12-20. PubMed ID: 27807928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of increased basic salivary proline-rich protein 1 levels in induced sputum with type 2-high asthma.
    Chen F; Liang Y; Zeng Z; Du L; Xu C; Guo Y; Xie C
    Immun Inflamm Dis; 2022 Apr; 10(4):e602. PubMed ID: 35344278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum induction and its diagnostic applications in inflammatory airway disorders: a review.
    Goncalves B; Eze UA
    Front Allergy; 2023; 4():1282782. PubMed ID: 37901763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophils in COPD: why should I care?
    Fernandes FL
    J Bras Pneumol; 2016; 42(4):237-238. PubMed ID: 27832227
    [No Abstract]   [Full Text] [Related]  

  • 11. Sputum periostin is a biomarker of type 2 inflammation but not airway dysfunction in asthma.
    Al-Shaikhly T; Murphy RC; Lai Y; Frevert CW; Debley JS; Ziegler SF; Wong K; Jia G; Holweg CTJ; Peters MC; Hallstrand TS
    Respirology; 2023 May; 28(5):491-494. PubMed ID: 36914406
    [No Abstract]   [Full Text] [Related]  

  • 12. Finding the Right Biological: Eosinophil Subset Differences in Asthma and Chronic Obstructive Pulmonary Disease.
    Freeman CM; Curtis JL; Hastie AT
    Am J Respir Crit Care Med; 2023 Jul; 208(2):121-123. PubMed ID: 37311240
    [No Abstract]   [Full Text] [Related]  

  • 13. Publisher Correction to: An integrated metabo‑lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD.
    Correnti S; Preianò M; Gamboni F; Stephenson D; Pelaia C; Pelaia G; Savino R; D'Alessandro A; Terracciano R
    J Transl Med; 2024 Apr; 22(1):334. PubMed ID: 38581013
    [No Abstract]   [Full Text] [Related]  

  • 14. Eosinophil cationic protein and chemokines in nasopharyngeal secretions of infants with respiratory syncytial virus (RSV) bronchiolitis and non-RSV bronchiolitis.
    Kim HH; Lee MH; Lee JS
    J Korean Med Sci; 2007 Feb; 22(1):37-42. PubMed ID: 17297249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic bronchitis: clinical manifestations and implications for treatment.
    Gibson PG; Fujimura M; Niimi A
    Thorax; 2002 Feb; 57(2):178-82. PubMed ID: 11828051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of sputum outcomes in chronic stable asthma.
    Rosi E; Ronchi MC; Grazzini M; Duranti R; Scano G
    Clin Exp Allergy; 2000 Apr; 30(4):577-84. PubMed ID: 10718857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood.
    Pizzichini E; Pizzichini MM; Efthimiadis A; Dolovich J; Hargreave FE
    J Allergy Clin Immunol; 1997 Apr; 99(4):539-44. PubMed ID: 9111500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis.
    Rosi E; Ronchi MC; Grazzini M; Duranti R; Scano G
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):232-7. PubMed ID: 9949313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of sputum ECP levels in differential diagnosis of asthma in children.
    Yazicioğlu M; Oneş U; Oneş DS; Salman N; Yalçin I; Güler N
    J Asthma; 1999 Sep; 36(6):493-502. PubMed ID: 10498044
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.